Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

Movember is back. Throughout the month of November, men are skipping their razors in favour of sporting a moustache to help ...

Consultant Urological Surgeon, Doctor Mark Laniardo revealed the worrying sensation that could be indicative of a cancerous ...

November is Men’s Health Awareness Month, a time to focus on health problems that affect men, especially prostate cancer and testicular cancer. These are two of the most common cancers in men, but ...

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

We transformed care for advanced prostate cancer, by validating inhibitors of androgen production as an effective cancer ...

A groundbreaking new study has found that a combination of two drugs can boost survival rates in prostate cancer patients by ...

A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Black men choose aggressive prostate cancer treatment—regardless of anticipated life expectancy—more often than Hispanic or ...